List of 85 drugs that were offered as generics for the first time in 2003
Democrats, Republicans Come Together to Condemn PBMs
In a House Committee on Oversight and Accountability hearing, Democrats and Republicans took a bipartisan stance to question the role major PBMs play regarding rising drug costs in the US.
Podcast: Is The Pharmacy World Prepared For DSCSA?
Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.
Q&A: What the NCPA is Doing to Fight Back Against PBMs
Steve Postal, JD, Director of Policy and Regulatory Affairs at the National Community Pharmacists Association (NCPA), discussed pharmacy benefit managers and vehicles necessary to induce reform.
Keep Up With Policy Changes Affecting Independent Pharmacy
This special Over the Counter episode, brought to you by Total Pharmacy® and Omega Pharmacy Group, dives into how to navigate the business of independent pharmacy and get ahead of key policy changes.
Medication, Health Care Affordability Improved During COVID-19 Pandemic
Researchers compared health care and prescription medication affordability during the COVID-19 pandemic to pre-pandemic numbers.
FTC Issues First Report Regarding Ongoing PBM Inquiry
The FTC released its interim report detailing PBM practices, staggering market consolidation statistics, and the disparities between PBMs and their smaller competitors.
